|
|
|
"We are dedicated to applying our industry-leading technology and expertise to further the development of Menveo and other vaccines that elicit robust, long-lasting, protective immune responses for all age groups at risk.
Studies have reported that Menveo generates a robust immune response against the four vaccine-preventable serogroups, A, C, W-135 and Y in people across age groups from infancy to adulthood. A Phase II study in infants published in the January 9, 2008, issue of the Journal of the American Medical Association reported that Menveo is the first meningococcal vaccine candidate to elicit a robust immune response in infants[1]. The company has already distributed more than 26 million doses of Menjugate around the world and produced MenZB, a vaccine against a strain of meningococcus B specific to a recent outbreak in New Zealand.com.2 billion.2 billion was invested in R&D activities throughout the Group. Meningococcal meningitis Fact sheet.D. Doses in the range of 5 to 10 mg/kg/d showed a more potent effect including more significant mitigation as assessed by histopathology and immunohistochemistry.
klonopin rating xanax buy cheap xanax img got fucked up smoking xanax hydroco apap 500mg xanax interaction mixing xanax and resterol overnight delivery on xanax xanax typical prescription
There is no vaccine currently licensed in the US for use in infants.
About meningococcal disease
Meningococcal disease can manifest as bacterial meningitis - an infection of the protective coverings of the brain and spinal cord - or meningococcemia - a bloodstream infection[2]. meningitidis).
Data to Be Presented at the 55th Annual Meeting of the Radiation Research Society in October
MISSION VIEJO, Calif.
“AEOL 10150 continues to demonstrate significant, protective effects when administered after exposure to radiation,” stated John L. In animal studies AEOL 10150 has demonstrated reductions in the markers for tissue hypoxia, angiogenesis, inflammation and oxidative stress.
AEOL 10150 offers several unique advantages as a countermeasure for the treatment of ARS, mustard gas and chlorine gas for civilian and military populations.
|
|
No News has been posted yet
|
|
|
Forgotten your password? Request a new one here.
|
 Guests Online: 1
No Members Online
Registered Members: 1
Unactivated Members: 0
Newest Member: Owen Electrical
|
|
v6.01.1 © 2003-2005